RBM15 facilitates osimertinib resistance of lung adenocarcinoma through m6A-dependent epigenetic silencing of SPOCK1. Li H, Li Y, Zheng X, Chen F, et al. Oncogene 2025;44:307-321.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li H, Li Y, Zheng X, Chen F, et al. RBM15 facilitates osimertinib resistance of lung adenocarcinoma through m6A-dependent epigenetic silencing of SPOCK1. Oncogene 2025;44:307-321.
PMID: 39528815